InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Couch post# 232809

Sunday, 08/30/2015 10:22:23 AM

Sunday, August 30, 2015 10:22:23 AM

Post# of 346493

And Bavi Phase II did not fail- if was successful even with botched data- allowing for phase 3 to commence.



Couch, you are correct! Even after sabotage, Peregrine recovered and salvaged the data and it still was significantly better = 60%.

I think we all wonder how good the data was if it was not tainted with and sabotaged. 200% or better is my guess

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News